Product Details

Our new 5 mL and first and only 10 mL ready-to-administer syringes and ready-to-use vials are now available to order through your wholesaler or directly through Nexus.

Hidden Accordion Tab

50 mg/10 mL, RTU Injection in a Vial

Unit of Sale NDC 14789-0250-10

Size 10 mL vial
Concentration 50 mg/10 mL (5 mg/mL)
Unit of Sale 10 vials per carton
Type Rx
Storage

Store at 20° to 25°C (68° to 77°F)
[See USP Controlled Room Temperature]
Active 50 mg ephedrine sulfate
Inactive Sodium chloride
Preservative-free Yes
Latex-free Yes – Vial closure is not made with natural rubber latex
Allergen-free Yes

Wholesaler Item Number
Cardinal 5644521
McKesson 1538644
Morris & Dickson 903617
Amerisource Bergen 10235817

Prescribing Information

50 mg/10 mL, Pre-Filled Syringe

Unit of Sale NDC 14789-0252-10

Size 10 mL syringe
Concentration 50 mg/10 mL (5 mg/mL)
Unit of Sale 10 syringes per carton
Type Rx
Storage

Store at 20° to 25°C (68° to 77°F)
[See USP Controlled Room Temperature]
Active 50 mg ephedrine sulfate
Inactive Sodium chloride
Preservative-free Yes
Latex-free Yes – Closure is not made with natural rubber latex
Allergen-free Yes

Wholesaler Item Number
Cardinal 5831920
McKesson 2688588
Morris & Dickson 261073
Amerisource Bergen 10277819

Prescribing Information

25 mg/5 mL, Pre-Filled Syringe

Unit of Sale NDC 14789-0251-10

Size 5 mL syringe
Concentration 25 mg/5 mL (5 mg/mL)
Unit of Sale 10 syringes per carton
Type Rx
Storage

Store at 20° to 25°C (68° to 77°F)
[See USP Controlled Room Temperature]
Active 25 mg ephedrine sulfate
Inactive Sodium chloride
Preservative-free Yes
Latex-free Yes – Closure is not made with natural rubber latex
Allergen-free Yes

Wholesaler Item Number
Cardinal 5831912
McKesson 2688596
Morris & Dickson 261056
Amerisource Bergen 10277755

Prescribing Information

Order directly through your Wholesaler or from Customer Service at (888) 806-4606

Under the Controlled Substances Act (CSA), your state may require additional licensing for dispensing EMERPHED® ready-to-use ephedrine.

For questions, please contact customer service at 888‑806‑4606.

What important safety infomation should I know?

CONTRAINDICATIONS
None

WARNINGS AND PRECAUTIONS
EMERPHED® can cause pressor effects with concomitant use with oxytocic drugs. Can also cause tachyphylaxis with repeated administration of ephedrine.

ADVERSE REACTIONS
Most common adverse reactions during treatment: nausea, vomiting, and tachycardia.
To report SUSPECTED ADVERSE REACTIONS, contact Nexus Pharmaceuticals at (855) 642-2594 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

DRUG INTERACTIONS
Can include: interactions that augment pressor effect; interactions that antagonize the pressor effect; guanethidine; rocuronium; epidural anesthesia; theophylline; cardiac glycosides.

OVERDOSAGE
Overdose of EMERPHED® can cause a rapid rise in blood pressure. In the case of an overdose, careful monitoring of blood pressure is recommended. If blood pressure continues to rise to an unacceptable level, parenteral antihypertensive agents can be administered at the discretion of the clinician.

INDICATIONS AND USAGE
Ephedrine Sulfate injection is an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.

For more information, see full Prescribing Information.

EPH-136-v2